Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Sphenopalatine Nerve Block for Headache Tx360

Phase 3

Completed

Conditions: Headache
Migraine

Interventions: Drug: Placebo
Drug: Bupivacaine

First Posted Date: 2013-09-11

Last Posted Date: 2015-07-27

Lead Sponsor: Indiana University

Target Recruit Count: 93

Registration Number: NCT01939314

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Endotracheal Tube Versus Laryngeal Mask Airway for Esophagogastroduodenoscopy

Not Applicable

Completed

Conditions: Airway Morbidity

Interventions: Device: LMA
Device: ETT

First Posted Date: 2013-09-06

Last Posted Date: 2016-05-02

Lead Sponsor: Indiana University

Target Recruit Count: 84

Registration Number: NCT01936662

Locations: 🇺🇸
Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States

Clinical Decision-support Reminders to Improve IPT Initiation Among HIV Positive Adults in Western Kenya

Not Applicable

Completed

Conditions: Tuberculosis

Interventions: Behavioral: TB reminders

First Posted Date: 2013-09-04

Last Posted Date: 2023-03-27

Lead Sponsor: Indiana University

Target Recruit Count: 3782

Registration Number: NCT01934309

Locations: 🇰🇪
AMPATH, Eldoret, Kenya

Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening

Phase 2

Completed

Conditions: Prolonged QT Interval in EKG and Sudden Death

Interventions: Drug: Progesterone
Drug: Placebo
Drug: Ibutilide

First Posted Date: 2013-08-27

Last Posted Date: 2015-10-30

Lead Sponsor: Indiana University

Target Recruit Count: 19

Registration Number: NCT01929083

Locations: 🇺🇸
Indiana Clinical Research Center, Indianapolis, Indiana, United States
🇺🇸
Purdue University, Indianapolis, Indiana, United States

A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Phase 1

Completed

Conditions: Hematopoetic Stem Cell Transplant

Interventions: Drug: Bortezomib administration

First Posted Date: 2013-08-21

Last Posted Date: 2018-03-22

Lead Sponsor: Indiana University

Target Recruit Count: 15

Registration Number: NCT01926899

Locations: 🇺🇸
Texas Transplant Institute, San Antonio, Texas, United States
🇺🇸
Indiana University, Indianapolis, Indiana, United States

Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)

Not Applicable

Terminated

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Procedure: PVI Ablation
Procedure: FIRM Ablation

First Posted Date: 2013-08-20

Last Posted Date: 2017-04-05

Lead Sponsor: Indiana University

Target Recruit Count: 1

Registration Number: NCT01925885

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response

Phase 2

Completed

Conditions: Fatigue

Interventions: Behavioral: Mindfulness-Based Stress Reduction
Behavioral: Attention Control

First Posted Date: 2013-08-09

Last Posted Date: 2015-01-05

Lead Sponsor: Indiana University

Target Recruit Count: 107

Registration Number: NCT01919853

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
Community Health Network--Community North and Carmel Pavilion, Carmel, Indiana, United States
🇺🇸
Invoke Yoga Studio, Indianapolis, Indiana, United States

and more 1 locations

Effect of Octreotide on the Colonic Motility in Pediatric Patients

Phase 4

Completed

Conditions: Colonic Motility Index
Constipation

Interventions: Drug: Octreotide
Drug: Bisacodyl

First Posted Date: 2013-08-07

Last Posted Date: 2015-12-21

Lead Sponsor: Indiana University

Target Recruit Count: 13

Registration Number: NCT01917773

Locations: 🇺🇸
Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,, Indianapolis, Indiana, United States

Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis

Phase 2

Completed

Conditions: Post-ERCP Pancreatitis

Interventions: Drug: high dose indomethacin
Drug: standard dose indomethacin

First Posted Date: 2013-07-31

Last Posted Date: 2019-07-05

Lead Sponsor: Indiana University

Target Recruit Count: 1037

Registration Number: NCT01912716

Locations: 🇺🇸
Aurora St. Lukes' Medical Center, Milwaukee, Wisconsin, United States
🇺🇸
Methodist Dallas Medical Center, Dallas, Texas, United States
🇺🇸
Indiana University Health, Indianapolis, Indiana, United States

and more 3 locations

Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation

Early Phase 1

Completed

Conditions: Liver Transplantation

First Posted Date: 2013-07-26

Last Posted Date: 2014-07-24

Lead Sponsor: Indiana University

Target Recruit Count: 1

Registration Number: NCT01909401

Locations: 🇺🇸
Indiana University School of Medicine - IUHealth-University Hospital, Indianapolis, Indiana, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy